Rare diseases
Investigational molecules
Locations
293 conditions with trials, the busiest first
1 664 trials across Europe, recruiting first
Study on the Effectiveness and Safety of VRDN-003 for Patients with Chronic Thyroid Eye Disease
GermanyStudy on the Safety and Effects of Baricitinib in People with HIV
SpainStudy on the Effectiveness and Safety of Tildrakizumab for Patients with Moderate to Severe Genital Psoriasis
BulgariaStudy on the Effects of Remibrutinib for Patients with Generalized Myasthenia Gravis
BelgiumStudy on the Effectiveness and Safety of Zasocitinib (TAK-279) for Patients with Active Psoriatic Arthritis with Previous Biologic Treatment
FranceStudy on the Effects of Ianalumab in Patients with Sjögren's Syndrome
FranceStudy on GSK5784283 for Adults Aged 18-75 with Uncontrolled Asthma
BulgariaStudy on the Safety and Effects of NVG-2089 for Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
BelgiumStudy of Teclistamab for Patients with Previously Treated AL Amyloidosis
FranceTitle: Study of Sibeprenlimab Treatment for Adults with Sjögren's Disease Using Subcutaneous Injections
BulgariaStudy on the Effectiveness and Safety of Lunsekimig (SAR443765) for Adults with Moderate to Severe Atopic Dermatitis
CzechiaStudy on the Effectiveness and Safety of RO7790121 for Patients with Moderate to Severe Atopic Dermatitis
FranceThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
